Cash flow HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
106.88 ^USD	+2.07%		+4.35%	+11.39%

Jan. 15	HealthEquity, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 08:15 AM
Jan. 14	Deutsche Bank Adjusts HealthEquity Price Target to $108 From $103, Maintains Buy Rating	MT

290446b89739d9b5f8b2.E2_kYTjOObmBLmqQlrds70MlJdRWuvaSzHgszkGIlnc.fQCyM3yDe4C5axja0PAkuCpfUYAu0Y_3pBBNuTfGzhlRCJ5MW55yyOpeMw

Published financial data: HEALTHEQUITY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2020	2021	2022	2023	2024
Revenues	532M	734M	757M	862M	1B
Other Revenues, Total	-	-	-	-	-
Total Revenues	532M	734M	757M	862M	1B
Cost of Goods Sold, Total	206M	318M	333M	372M	377M
Gross Profit	326M	415M	424M	490M	623M
Selling General & Admin Expenses, Total	105M	134M	143M	164M	183M
R&D Expenses	77.58M	125M	157M	193M	219M
Amortization of Goodwill and Intangible Assets - (IS)	34.7M	76.06M	82.79M	94.59M	92.76M
Other Operating Expenses, Total	217M	335M	383M	452M	495M
Operating Income	109M	80M	40.57M	37.65M	128M
Interest Expense, Total	-24.77M	-34.88M	-36.57M	-48.42M	-55.46M
Interest And Investment Income	5.9M	1.04M	1.5M	1.76M	12.14M
Net Interest Expenses	-18.87M	-33.84M	-35.07M	-46.66M	-43.32M
Other Non Operating Income (Expenses)	-1.93M	-1.72M	1.71M	-439K	658K
EBT, Excl. Unusual Items	88.32M	44.45M	7.2M	-9.45M	85.48M
Merger & Related Restructuring Charges	-72.92M	-47.11M	-75.64M	-28.65M	-10.44M
Gain (Loss) On Sale Of Investments	27.76M	-	1.69M	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Legal Settlements	-	6.8M	-	-	-
EBT, Incl. Unusual Items	43.16M	4.14M	-66.74M	-38.1M	75.04M
Income Tax Expense	3.49M	-4.69M	-22.45M	-11.95M	19.33M
Earnings From Continuing Operations	39.66M	8.83M	-44.29M	-26.14M	55.71M
Net Income to Company	39.66M	8.83M	-44.29M	-26.14M	55.71M
Net Income - (IS)	39.66M	8.83M	-44.29M	-26.14M	55.71M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	39.66M	8.83M	-44.29M	-26.14M	55.71M
Net Income to Common Excl. Extra Items	39.66M	8.83M	-44.29M	-26.14M	55.71M
Per Share Items
Net EPS - Basic	0.59	0.12	-0.53	-0.31	0.65
Basic EPS - Continuing Operations	0.59	0.12	-0.53	-0.31	0.65
Basic Weighted Average Shares Outstanding	67.03M	74.24M	83.13M	84.44M	85.56M
Net EPS - Diluted	0.58	0.12	-0.53	-0.31	0.64
Diluted EPS - Continuing Operations	0.58	0.12	-0.53	-0.31	0.64
Diluted Weighted Average Shares Outstanding	68.45M	75.68M	83.13M	84.44M	86.96M
Normalized Basic EPS	0.82	0.37	0.05	-0.07	0.62
Normalized Diluted EPS	0.81	0.37	0.05	-0.07	0.61
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	164M	196M	178M	199M	281M
EBITA	156M	180M	163M	187M	272M
EBIT	109M	80M	40.57M	37.65M	128M
EBITDAR	173M	210M	191M	208M	288M
Total Revenues (As Reported)	532M	734M	757M	862M	1B
Effective Tax Rate - (Ratio)	8.09	-113.38	33.64	31.38	25.76
Current Domestic Taxes	-174K	439K	867K	5.23M	33.32M
Total Current Taxes	-174K	439K	867K	5.23M	33.32M
Deferred Domestic Taxes	3.66M	-5.13M	-23.32M	-17.18M	-14M
Total Deferred Taxes	3.66M	-5.13M	-23.32M	-17.18M	-14M
Normalized Net Income	55.2M	27.78M	4.5M	-5.9M	53.42M
Interest on Long-Term Debt	24.77M	34.88M	36.57M	48.42M	55.46M
Supplemental Operating Expense Items
Selling and Marketing Expenses	43.95M	49.96M	58.6M	68.85M	79.27M
General and Administrative Expenses	60.56M	84.49M	84.38M	95.63M	104M
Research And Development Expense From Footnotes	77.58M	125M	157M	193M	219M
Net Rental Expense, Total	8.31M	14.27M	12.93M	9.18M	6.76M
Imputed Operating Lease Interest Expense	-	3.35M	3.63M	3.55M	3.11M
Imputed Operating Lease Depreciation	-	10.92M	9.3M	5.63M	3.65M
Stock-Based Comp., COGS (Total)	4.79M	8M	11.26M	14.43M	16.46M
Stock-Based Comp., R&D Exp. (Total)	7.65M	10.77M	13.13M	13.83M	20.89M
Stock-Based Comp., S&M Exp. (Total)	4.69M	6.99M	7M	9.82M	13.18M
Stock-Based Comp., G&A Exp. (Total)	12.97M	17.11M	21.36M	24.54M	26.62M
Stock-Based Comp., Other (Total)	15.32M	-	342K	-	-
Total Stock-Based Compensation	45.42M	42.86M	53.09M	62.61M	77.15M

Fiscal Period: January	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	192M	329M	225M	254M	404M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	192M	329M	225M	254M	404M
Accounts Receivable, Total	70.86M	72.77M	87.43M	96.84M	105M
Total Receivables	70.86M	72.77M	87.43M	96.84M	105M
Inventory	-	-	-	-	-
Prepaid Expenses	-	-	-	20.1M	31.2M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	34.71M	58.61M	38.5M	11.69M	17.36M
Total Current Assets	297M	460M	351M	383M	557M
Gross Property Plant And Equipment	132M	150M	123M	111M	95.41M
Accumulated Depreciation	-15.76M	-30.99M	-35.6M	-41.82M	-41.02M
Net Property Plant And Equipment	117M	119M	86.98M	69.32M	54.39M
Long-term Investments	-	-	-	-	-
Goodwill	1.33B	1.33B	1.65B	1.65B	1.65B
Other Intangibles, Total	783M	767M	973M	936M	836M
Deferred Tax Assets Long-Term	18K	-	-	-	-
Deferred Charges Long-Term	6.4M	5M	4.4M	3.4M	2.5M
Other Long-Term Assets, Total	28.69M	32.42M	45.41M	48.78M	65.37M
Total Assets	2.56B	2.71B	3.11B	3.09B	3.16B
Liabilities
Accounts Payable, Total	3.98M	1.61M	27.54M	13.9M	12.04M
Accrued Expenses, Total	96.49M	127M	105M	89.5M	95.65M
Current Portion of Long-Term Debt	39.06M	62.5M	8.75M	17.5M	-
Current Portion of Leases	12.4M	14.04M	12.17M	10.16M	9.4M
Total Current Liabilities	152M	205M	153M	131M	117M
Long-Term Debt	1.18B	924M	922M	908M	875M
Long-Term Leases	68.02M	74.22M	65.23M	58.99M	48.77M
Deferred Tax Liability Non Current	130M	120M	99.85M	82.66M	68.67M
Other Non Current Liabilities	2.62M	8.81M	14.18M	12.71M	19.27M
Total Liabilities	1.53B	1.33B	1.25B	1.19B	1.13B
Common Stock, Total	7K	8K	8K	8K	9K
Additional Paid In Capital	819M	1.16B	1.68B	1.75B	1.83B
Retained Earnings	212M	220M	176M	150M	206M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	1.03B	1.38B	1.85B	1.9B	2.04B
Total Equity	1.03B	1.38B	1.85B	1.9B	2.04B
Total Liabilities And Equity	2.56B	2.71B	3.11B	3.09B	3.16B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	71.08M	83.02M	83.82M	84.78M	86.16M
ECS Total Common Shares Outstanding	71.05M	77.17M	83.78M	84.76M	86.13M
Book Value / Share	14.5	17.87	22.11	22.37	23.63
Tangible Book Value	-1.09B	-715M	-766M	-689M	-449M
Tangible Book Value Per Share	-15.28	-9.27	-9.15	-8.13	-5.21
Total Debt	1.3B	1.07B	1.01B	994M	933M
Net Debt	1.11B	746M	783M	740M	529M
Debt Equivalent Oper. Leases	66.47M	114M	103M	73.47M	54.06M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	-	3	3
Inventories - Others	-	-	-	-	-
Machinery, Total	30M	37.82M	40.4M	36.41M	32.58M
Full Time Employees	2.93K	3K	3.69K	3.17K	3.13K
Part Time Employees	-	38	27	38	24
Accumulated Allowance for Doubtful Accounts (Supple)	1.22M	4.24M	6.23M	4.99M	3.95M

Fiscal Period: January	2020	2021	2022	2023	2024
Net Income	39.66M	8.83M	-44.29M	-26.14M	55.71M
Depreciation & Amortization - CF	8.85M	16M	14.69M	12.3M	8.78M
Amortization of Goodwill and Intangible Assets - (CF)	46.5M	99.9M	122M	149M	144M
Depreciation & Amortization, Total	55.35M	116M	137M	161M	153M
Amortization of Deferred Charges, Total - (CF)	-	5.1M	4.45M	3.26M	2.85M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-23.15M	-	-1.68M	-	-
Asset Writedown & Restructuring Costs	-	-	11.25M	-	-
Stock-Based Compensation (CF)	39.84M	42.86M	52.75M	62.61M	77.15M
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	3.66M	-3.38M	-20.3M	-16.91M	-12.84M
Change In Accounts Receivable	-5.01M	-413K	-11.2M	-9.57M	-8.06M
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	-3.84M	30.42M	-2.18M	-26.67M	-204K
Change in Other Net Operating Assets	-1.52M	-17.71M	15.01M	2.87M	-24.87M
Cash from Operations	105M	182M	141M	151M	243M
Capital Expenditure	-7.29M	-13.09M	-8.91M	-3.37M	-1.69M
Cash Acquisitions	-1.64B	-	-505M	-	-
Sale (Purchase) of Intangible assets	-34.79M	-83.87M	-128M	-116M	-44.38M
Investment in Marketable and Equity Securities, Total	-53.84M	-	2.37M	-	-
Cash from Investing	-1.74B	-96.96M	-639M	-119M	-46.07M
Long-Term Debt Issued, Total	1.25B	-	950M	-	-
Total Debt Issued	1.25B	-	950M	-	-
Long-Term Debt Repaid, Total	-7.81M	-239M	-1B	-8.75M	-54.38M
Total Debt Repaid	-7.81M	-239M	-1B	-8.75M	-54.38M
Issuance of Common Stock	470M	295M	466M	6.68M	6.47M
Common Dividends Paid	-	-	-	-	-
Preferred Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-246M	-3.86M	-18.41M	-603K	865K
Cash from Financing	1.47B	52.42M	395M	-2.67M	-47.04M
Net Change in Cash	-170M	137M	-103M	28.85M	150M
Supplemental Items
Cash Interest Paid	21.81M	27.69M	16.11M	43.57M	49.56M
Cash Income Tax Paid (Refund)	9.28M	-6.02M	-5.63M	1.53M	35.35M
Levered Free Cash Flow	110M	97M	69.7M	69.65M	212M
Unlevered Free Cash Flow	126M	114M	88.11M	96.65M	244M
Change In Net Working Capital	952K	-1.89M	-9.55M	31.57M	20.54M
Net Debt Issued / Repaid	1.24B	-239M	-53.12M	-8.75M	-54.38M

Fiscal Period: January	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.44	1.9	0.87	0.76	2.56
Return on Total Capital	4.86	2.09	0.95	0.82	2.73
Return On Equity %	5.26	0.73	-2.74	-1.39	2.83
Return on Common Equity	5.26	0.73	-2.74	-1.39	2.83
Margin Analysis
Gross Profit Margin %	61.26	56.62	56	56.87	62.29
SG&A Margin	19.65	18.33	18.9	19.09	18.3
EBITDA Margin %	30.92	26.71	23.5	23.08	28.13
EBITA Margin %	29.25	24.52	21.55	21.65	27.25
EBIT Margin %	20.51	10.91	5.36	4.37	12.82
Income From Continuing Operations Margin %	7.46	1.2	-5.85	-3.03	5.57
Net Income Margin %	7.46	1.2	-5.85	-3.03	5.57
Net Avail. For Common Margin %	7.46	1.2	-5.85	-3.03	5.57
Normalized Net Income Margin	10.38	3.79	0.6	-0.69	5.34
Levered Free Cash Flow Margin	20.76	13.22	9.21	8.08	21.2
Unlevered Free Cash Flow Margin	23.67	15.5	11.65	11.22	24.38
Asset Turnover
Asset Turnover	0.35	0.28	0.26	0.28	0.32
Fixed Assets Turnover	8.52	6.24	7.36	11.03	16.16
Receivables Turnover (Average Receivables)	11.02	10.21	9.45	9.35	9.91
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.96	2.25	2.29	2.92	4.76
Quick Ratio	1.73	1.96	2.04	2.68	4.35
Operating Cash Flow to Current Liabilities	0.69	0.89	0.92	1.15	2.07
Days Sales Outstanding (Average Receivables)	33.11	35.83	38.64	39.02	36.83
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	6.64	3.22	15.99	20.35	12.56
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	126.28	77.97	54.42	52.46	45.85
Total Debt / Total Capital	55.81	43.81	35.24	34.41	31.44
LT Debt/Equity	121.29	72.42	53.29	51	45.39
Long-Term Debt / Total Capital	53.6	40.69	34.51	33.45	31.12
Total Liabilities / Total Assets	59.83	49.13	40.38	38.63	35.68
EBIT / Interest Expense	4.4	2.29	1.11	0.78	2.31
EBITDA / Interest Expense	6.97	6.03	5.21	4.3	5.19
(EBITDA - Capex) / Interest Expense	6.68	5.65	4.97	4.23	5.16
Total Debt / EBITDA	7.53	5.11	5.29	4.78	3.24
Net Debt / EBITDA	6.42	3.55	4.11	3.56	1.84
Total Debt / (EBITDA - Capex)	7.86	5.45	5.55	4.86	3.26
Net Debt / (EBITDA - Capex)	6.7	3.79	4.31	3.62	1.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	85.21	37.89	3.13	13.9	16
Gross Profit, 1 Yr. Growth %	79.87	27.44	2.02	15.67	26.57
EBITDA, 1 Yr. Growth %	71.58	19.12	-9.27	11.87	41.42
EBITA, 1 Yr. Growth %	68.47	15.61	-9.36	14.4	46.04
EBIT, 1 Yr. Growth %	40.49	-26.68	-49.29	-7.18	240.3
Earnings From Cont. Operations, 1 Yr. Growth %	-46.33	-77.73	-601.35	-40.97	-313.1
Net Income, 1 Yr. Growth %	-46.33	-77.73	-601.35	-40.97	-313.1
Normalized Net Income, 1 Yr. Growth %	13.17	-49.67	-85.94	-231.14	-1K
Diluted EPS Before Extra, 1 Yr. Growth %	-50.43	-79.48	-547.69	-41.81	-306.45
Accounts Receivable, 1 Yr. Growth %	176.08	2.69	20.15	10.76	8.32
Inventory, 1 Yr. Growth %